1. Home
  2. COHU vs IMCR Comparison

COHU vs IMCR Comparison

Compare COHU & IMCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cohu Inc.

COHU

Cohu Inc.

HOLD

Current Price

$38.93

Market Cap

1.5B

Sector

Industrials

ML Signal

HOLD

Logo Immunocore Holdings plc

IMCR

Immunocore Holdings plc

HOLD

Current Price

$31.53

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
COHU
IMCR
Founded
1947
2008
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Electrical Products
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.7B
IPO Year
1994
2016

Fundamental Metrics

Financial Performance
Metric
COHU
IMCR
Price
$38.93
$31.53
Analyst Decision
Strong Buy
Buy
Analyst Count
5
10
Target Price
$34.00
$66.33
AVG Volume (30 Days)
619.8K
395.0K
Earning Date
04-30-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
30.39
EPS
N/A
N/A
Revenue
$452,956,000.00
$249,428,000.00
Revenue This Year
$14.38
$14.57
Revenue Next Year
$19.12
$8.21
P/E Ratio
N/A
N/A
Revenue Growth
12.74
43.05
52 Week Low
$13.66
$27.47
52 Week High
$39.24
$40.71

Technical Indicators

Market Signals
Indicator
COHU
IMCR
Relative Strength Index (RSI) 76.48 52.33
Support Level $27.68 $31.08
Resistance Level N/A $31.65
Average True Range (ATR) 1.61 1.15
MACD 0.80 0.20
Stochastic Oscillator 97.21 67.81

Price Performance

Historical Comparison
COHU
IMCR

About COHU Cohu Inc.

Cohu Inc is a supplier of semiconductor test and inspection handlers, micro-electro-mechanical system (MEMS) test modules, test contactors, and thermal sub-systems used by semiconductor manufacturers and test subcontractors. The company's products include Semiconductor ATE (Automated Test Equipment), Semiconductor Handlers, Interface Products such as test contactors, probe heads and probe pins, Spares and Kits, Bare Board PCB Test Systems, and services. It has one reportable segment, Semiconductor Test and Inspection Equipment (Semiconductor Test & Inspection).

About IMCR Immunocore Holdings plc

Immunocore Holdings PLC is a commercial-stage biotechnology company. Using its ImmTAX platform, the company is developing a deep pipeline in multiple therapeutic areas, including clinical stage programs in oncology and infectious disease, pre-clinical programs in autoimmune disease, and earlier pre-clinical programs across three therapeutic areas. The company's main product, KIMMTRAK, is used for the treatment of unresectable or metastatic uveal melanoma (mUM). The other drug candidates in its pipeline include Brenetafusp, IMC-P115C, IMC-T119C, IMC-R117C, IMC-S118AI, IMC-U120AI, and others, being developed as a potential treatment for various oncology, infectious, and autoimmune diseases.

Share on Social Networks: